ScopusElsevier Scopus
Status
Active
Coverage
2009–2026
Source type
Journal
Open access
Yes
CiteScore
4.8
Best quartile
Q2 · 52nd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 155 / 328 | 52nd | Q2 |
| Molecular Medicine | 109 / 179 | 39th | Q3 |
Pharmacogenomics and Personalized Medicine
ISSN 1178-7066
Publisher: Dove Medical Press Ltd
Scopus · Q2WoS · SCIEOpen Access
Is Pharmacogenomics and Personalized Medicine indexed in Scopus? Yes — actively indexed in Scopus, coverage 2009–2026, best quartile Q2, CiteScore 4.8.
Is Pharmacogenomics and Personalized Medicine in Web of Science? Yes — indexed in the Science Citation Index Expanded.
Is Pharmacogenomics and Personalized Medicine open access? Yes — it is an open-access journal, listed in DOAJ.
4.8
CiteScore 2025
Scopus
Q2
Best quartile
52nd percentile
3
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
- Psychology Research and Behavior Management
- Research and Reports in Urology
- Risk Management and Healthcare Policy
- Stem Cells and Cloning: Advances and Applications
- Therapeutics and Clinical Risk Management
- Transplant Research and Risk Management
- Vascular Health and Risk Management
- Advances and Applications in Bioinformatics and Chemistry
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.